| Application no. and date | 10771102.0 (espacenet) (Federated) (European Patent Register), 20101027 | | Patent/reg. no. and date | DK/EP 2493503, 20150812 | | Publication date | 20120905 | | Priority no. and date | US 255290 P, 20091027, EP 09174104, 20091027 | | EP pub. no. and date |
EP 2493503 20120905 | | Effective date | | | Applicant/owner | Amgen Research (Munich) GmbH, Staffelseestrasse 2
81477 München, DE | | Applicant ref. no. | P2005DKEP | | Inventor | NAGORSEN, Dirk, c/o Amgen Research (Munich) GmbH,
Staffelseestrasse 2
81477 Munich, DE,
KUFER, Peter, c/o Amgen Research (Munich) GmbH,
Staffelseestrasse 2
81477 Munich, DE,
ZUGMAIER, Gerhard, c/o Amgen Research (Munich) GmbH,
Staffelseestrasse 2
81477 Munich, DE,
BAEUERLE, Patrick, c/o Amgen Research (Munich) GmbH,
Staffelseestrasse 2
81477 Munich, DE | | Representative | KIPA AB, Drottninggatan 11
SE-252 21 Helsingborg, SE | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , C07K 16/28 (2006.01) , G01N 33/50 (2006.01) | | Title | DOSERINGSPLAN FOR ADMINISTRERING AF ET CD19XCD3-BISPECIFIKT ANTISTOF | | Int. application no. | EP2010066207 | | Int. publication no. | WO2011051307 | | Related patent (certificate) | | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
